Filing Details

Accession Number:
0001127602-23-006642
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-23 09:54:27
Reporting Period:
2023-02-21
Accepted Time:
2023-02-23 09:54:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
920148 Laboratory Corp Of America Holdings LH Services-Medical Laboratories (8071) 133757370
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1791393 R Paul Kirchgraber 531 South Spring Street
Burlington NC 27215
Ceo, Covance Drug Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-02-21 3,000 $182.51 17,069 No 4 M Direct
Common Stock Disposition 2023-02-21 8,000 $250.58 9,069 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified Stock Options Disposition 2023-02-21 3,000 $0.00 3,000 $182.51
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,300 2021-02-04 2030-02-03 No 4 M Direct
Footnotes
  1. The price of $250.5844 per share represents a weighted average of sales prices ranging from $250.44 to $250.79 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a securityholder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  2. Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
  3. The option vested in three equal annual installments beginning on the date reflected in this column.